123I-mIBG |
123I-meta-iodobenzylguanidine |
ACE-I |
angiotensin-converting enzyme inhibitors |
ACS |
acute coronary syndrome |
ARB |
angiotensin receptor blockers |
ARNI |
angiotensin-receptor neprilysine-inhibitor |
BNP |
brain natriuretic peptide |
β-AR |
β-adrenergic receptors |
CHF |
chronic heart failure |
CZT |
Cadmium–Zinc–Telluride |
FBBG |
Flubrobenguane |
ICD |
implantable cardioverter defibrillator |
HED |
hydroxyephedrine |
HFPEF |
heart failure with preserved ejection fraction |
HFREF |
heart failure with reduced ejection fraction |
HRV |
heart rate variability |
H/M |
heart-to-mediastinum ratio |
LBBB |
left bundle branch block |
LVEF |
left ventricular ejection fraction |
LVESV |
left ventricular end systolic volume |
MAO |
monoamine oxidase |
MPI |
myocardial perfusion imaging |
NE |
norepinephrine |
NET |
norepinephrine transporter |
NYHA |
New York heart association |
OMT |
optimal medical therapy |
ROI |
region-of-interest |
SCD |
sudden cardiac death |
SDS |
summed defect score |
SGLT2 inhibitor |
sodium-glucose cotransporter-2 inhibitor |
SPECT |
single-photon emission tomography |
TCM |
takotsubo cardiomyopathy |
WO |
washout |